Soo Youn Bae, Sangmin Kim, Jun Ho Lee, Hyun-Chul Lee, Se Kyung Lee, Won Ho Kil, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam. BMC Cancer 2015
Times Cited: 78
Times Cited: 78
Times Cited
Times Co-cited
Similarity
Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Emad A Rakha, Maysa E El-Sayed, Andrew R Green, E Claire Paish, Desmond G Powe, Julia Gee, Robert I Nicholson, Andrew H S Lee, John F R Robertson, Ian O Ellis. J Clin Oncol 2007
Emad A Rakha, Maysa E El-Sayed, Andrew R Green, E Claire Paish, Desmond G Powe, Julia Gee, Robert I Nicholson, Andrew H S Lee, John F R Robertson, Ian O Ellis. J Clin Oncol 2007
25
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
Xiaojiang Cui, Rachel Schiff, Grazia Arpino, C Kent Osborne, Adrian V Lee. J Clin Oncol 2005
Xiaojiang Cui, Rachel Schiff, Grazia Arpino, C Kent Osborne, Adrian V Lee. J Clin Oncol 2005
24
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.
Aleix Prat, Maggie Chon U Cheang, Miguel Martín, Joel S Parker, Eva Carrasco, Rosalía Caballero, Scott Tyldesley, Karen Gelmon, Philip S Bernard, Torsten O Nielsen,[...]. J Clin Oncol 2013
Aleix Prat, Maggie Chon U Cheang, Miguel Martín, Joel S Parker, Eva Carrasco, Rosalía Caballero, Scott Tyldesley, Karen Gelmon, Philip S Bernard, Torsten O Nielsen,[...]. J Clin Oncol 2013
24
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
23
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.
Valerie-Jeanne Bardou, Grazia Arpino, Richard M Elledge, C Kent Osborne, Gary M Clark. J Clin Oncol 2003
Valerie-Jeanne Bardou, Grazia Arpino, Richard M Elledge, C Kent Osborne, Gary M Clark. J Clin Oncol 2003
20
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Lisa K Dunnwald, Mary Anne Rossing, Christopher I Li. Breast Cancer Res 2007
Lisa K Dunnwald, Mary Anne Rossing, Christopher I Li. Breast Cancer Res 2007
19
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.
C A Purdie, P Quinlan, L B Jordan, A Ashfield, S Ogston, J A Dewar, A M Thompson. Br J Cancer 2014
C A Purdie, P Quinlan, L B Jordan, A Ashfield, S Ogston, J A Dewar, A M Thompson. Br J Cancer 2014
19
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Grazia Arpino, Heidi Weiss, Adrian V Lee, Rachel Schiff, Sabino De Placido, C Kent Osborne, Richard M Elledge. J Natl Cancer Inst 2005
Grazia Arpino, Heidi Weiss, Adrian V Lee, Rachel Schiff, Sabino De Placido, C Kent Osborne, Richard M Elledge. J Natl Cancer Inst 2005
16
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, Philippe Moerman, Nathalie Pochet, Wouter Hendrickx, Hans Wildiers, Robert Paridaens, Ann Smeets, Marie-Rose Christiaens,[...]. J Clin Oncol 2008
Leen De Maeyer, Erik Van Limbergen, Katelijne De Nys, Philippe Moerman, Nathalie Pochet, Wouter Hendrickx, Hans Wildiers, Robert Paridaens, Ann Smeets, Marie-Rose Christiaens,[...]. J Clin Oncol 2008
14
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
12
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
12
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype.
Marco M Hefti, Rong Hu, Nicholas W Knoblauch, Laura C Collins, Benjamin Haibe-Kains, Rulla M Tamimi, Andrew H Beck. Breast Cancer Res 2013
Marco M Hefti, Rong Hu, Nicholas W Knoblauch, Laura C Collins, Benjamin Haibe-Kains, Rulla M Tamimi, Andrew H Beck. Breast Cancer Res 2013
12
Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
Syed Salahuddin Ahmed, Aye Aye Thike, Kathryn Zhang, Jeffrey Chun Tatt Lim, Puay Hoon Tan. J Clin Pathol 2017
Syed Salahuddin Ahmed, Aye Aye Thike, Kathryn Zhang, Jeffrey Chun Tatt Lim, Puay Hoon Tan. J Clin Pathol 2017
43
Time to stop progesterone receptor testing in breast cancer management.
Ivo A Olivotto, Pauline T Truong, Caroline H Speers, Vanessa Bernstein, Sharon J Allan, Seamus J Kelly, Mary L Lesperance. J Clin Oncol 2004
Ivo A Olivotto, Pauline T Truong, Caroline H Speers, Vanessa Bernstein, Sharon J Allan, Seamus J Kelly, Mary L Lesperance. J Clin Oncol 2004
16
Lack of either estrogen or progesterone receptor expression is associated with poor survival outcome among luminal A breast cancer subtype.
Seho Park, Byeong-Woo Park, Tae Hyun Kim, Chang Wan Jeon, Han-Sung Kang, Jung-Eun Choi, Ki-Tae Hwang, In Cheol Kim. Ann Surg Oncol 2013
Seho Park, Byeong-Woo Park, Tae Hyun Kim, Chang Wan Jeon, Han-Sung Kang, Jung-Eun Choi, Ki-Tae Hwang, In Cheol Kim. Ann Surg Oncol 2013
36
Progesterone receptor modulates ERα action in breast cancer.
Hisham Mohammed, I Alasdair Russell, Rory Stark, Oscar M Rueda, Theresa E Hickey, Gerard A Tarulli, Aurelien A Serandour, Stephen N Birrell, Alejandra Bruna, Amel Saadi,[...]. Nature 2015
Hisham Mohammed, I Alasdair Russell, Rory Stark, Oscar M Rueda, Theresa E Hickey, Gerard A Tarulli, Aurelien A Serandour, Stephen N Birrell, Alejandra Bruna, Amel Saadi,[...]. Nature 2015
11
Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.
Jia-Yuan Sun, San-Gang Wu, Feng-Yan Li, Huan-Xin Lin, Zhen-Yu He. Onco Targets Ther 2016
Jia-Yuan Sun, San-Gang Wu, Feng-Yan Li, Huan-Xin Lin, Zhen-Yu He. Onco Targets Ther 2016
75
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Giuseppe Viale, Meredith M Regan, Eugenio Maiorano, Mauro G Mastropasqua, Patrizia Dell'Orto, Birgitte Bruun Rasmussen, Johnny Raffoul, Patrick Neven, Zsolt Orosz, Stephen Braye,[...]. J Clin Oncol 2007
Giuseppe Viale, Meredith M Regan, Eugenio Maiorano, Mauro G Mastropasqua, Patrizia Dell'Orto, Birgitte Bruun Rasmussen, Johnny Raffoul, Patrick Neven, Zsolt Orosz, Stephen Braye,[...]. J Clin Oncol 2007
11
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
10
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
A Goldhirsch, E P Winer, A S Coates, R D Gelber, M Piccart-Gebhart, B Thürlimann, H-J Senn. Ann Oncol 2013
A Goldhirsch, E P Winer, A S Coates, R D Gelber, M Piccart-Gebhart, B Thürlimann, H-J Senn. Ann Oncol 2013
10
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
A S Coates, E P Winer, A Goldhirsch, R D Gelber, M Gnant, M Piccart-Gebhart, B Thürlimann, H-J Senn. Ann Oncol 2015
A S Coates, E P Winer, A Goldhirsch, R D Gelber, M Gnant, M Piccart-Gebhart, B Thürlimann, H-J Senn. Ann Oncol 2015
10
Intrinsic breast cancer subtypes defined by estrogen receptor signalling-prognostic relevance of progesterone receptor loss.
Lisa Braun, Friederike Mietzsch, Petra Seibold, Andreas Schneeweiss, Peter Schirmacher, Jenny Chang-Claude, Hans Peter Sinn, Sebastian Aulmann. Mod Pathol 2013
Lisa Braun, Friederike Mietzsch, Petra Seibold, Andreas Schneeweiss, Peter Schirmacher, Jenny Chang-Claude, Hans Peter Sinn, Sebastian Aulmann. Mod Pathol 2013
22
Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.
Mehrdad Nadji, Carmen Gomez-Fernandez, Parvin Ganjei-Azar, Azorides R Morales. Am J Clin Pathol 2005
Mehrdad Nadji, Carmen Gomez-Fernandez, Parvin Ganjei-Azar, Azorides R Morales. Am J Clin Pathol 2005
10
Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer.
Tiansheng Shen, Margaret Brandwein-Gensler, Omar Hameed, Gene P Siegal, Shi Wei. Hum Pathol 2015
Tiansheng Shen, Margaret Brandwein-Gensler, Omar Hameed, Gene P Siegal, Shi Wei. Hum Pathol 2015
30
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson,[...]. N Engl J Med 2018
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson,[...]. N Engl J Med 2018
10
Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Yunhai Li, Dejuan Yang, Xuedong Yin, Xiang Zhang, Jiefeng Huang, Yusheng Wu, Mengxue Wang, Zhiying Yi, Hongyuan Li, Hongzhong Li,[...]. JAMA Netw Open 2020
Yunhai Li, Dejuan Yang, Xuedong Yin, Xiang Zhang, Jiefeng Huang, Yusheng Wu, Mengxue Wang, Zhiying Yi, Hongyuan Li, Hongzhong Li,[...]. JAMA Netw Open 2020
26
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
A Goldhirsch, W C Wood, A S Coates, R D Gelber, B Thürlimann, H-J Senn. Ann Oncol 2011
A Goldhirsch, W C Wood, A S Coates, R D Gelber, B Thürlimann, H-J Senn. Ann Oncol 2011
8
Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment.
Ke-da Yu, Gen-hong Di, Jiong Wu, Jin-song Lu, Kun-wei Shen, Guang-yu Liu, Zhen-zhou Shen, Zhio-ming Shao. J Cancer Res Clin Oncol 2008
Ke-da Yu, Gen-hong Di, Jiong Wu, Jin-song Lu, Kun-wei Shen, Guang-yu Liu, Zhen-zhou Shen, Zhio-ming Shao. J Cancer Res Clin Oncol 2008
20
Risk factors for breast cancer according to estrogen and progesterone receptor status.
Graham A Colditz, Bernard A Rosner, Wendy Y Chen, Michelle D Holmes, Susan E Hankinson. J Natl Cancer Inst 2004
Graham A Colditz, Bernard A Rosner, Wendy Y Chen, Michelle D Holmes, Susan E Hankinson. J Natl Cancer Inst 2004
7
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.
G Cancello, P Maisonneuve, N Rotmensz, G Viale, M G Mastropasqua, G Pruneri, E Montagna, M Iorfida, M Mazza, A Balduzzi,[...]. Ann Oncol 2013
G Cancello, P Maisonneuve, N Rotmensz, G Viale, M G Mastropasqua, G Pruneri, E Montagna, M Iorfida, M Mazza, A Balduzzi,[...]. Ann Oncol 2013
8
7
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
7
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
7
Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.
Ying Fan, Xiaoyan Ding, Binghe Xu, Fei Ma, Peng Yuan, Jiayu Wang, Pin Zhang, Qing Li, Yang Luo. Medicine (Baltimore) 2015
Ying Fan, Xiaoyan Ding, Binghe Xu, Fei Ma, Peng Yuan, Jiayu Wang, Pin Zhang, Qing Li, Yang Luo. Medicine (Baltimore) 2015
50
Estrogen receptor negative and progesterone receptor positive breast carcinomas-how frequent are they?
Gábor Cserni, Monika Francz, Endre Kálmán, Gyöngyi Kelemen, Detre Csaba Komjáthy, Ilona Kovács, Janina Kulka, László Sarkadi, Nóra Udvarhelyi, László Vass,[...]. Pathol Oncol Res 2011
Gábor Cserni, Monika Francz, Endre Kálmán, Gyöngyi Kelemen, Detre Csaba Komjáthy, Ilona Kovács, Janina Kulka, László Sarkadi, Nóra Udvarhelyi, László Vass,[...]. Pathol Oncol Res 2011
24
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Mitsuya Itoh, Takayuki Iwamoto, Junji Matsuoka, Tomohiro Nogami, Takayuki Motoki, Tadahiko Shien, Naruto Taira, Naoki Niikura, Naoki Hayashi, Shoichiro Ohtani,[...]. Breast Cancer Res Treat 2014
Mitsuya Itoh, Takayuki Iwamoto, Junji Matsuoka, Tomohiro Nogami, Takayuki Motoki, Tadahiko Shien, Naruto Taira, Naoki Niikura, Naoki Hayashi, Shoichiro Ohtani,[...]. Breast Cancer Res Treat 2014
10
Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer.
Melissa Chan, Martin C Chang, Rosa González, Belinda Lategan, Elvira del Barco, Francisco Vera-Badillo, Paula Quesada, Robyn Goldstein, Ignacio Cruz, Alberto Ocana,[...]. PLoS One 2015
Melissa Chan, Martin C Chang, Rosa González, Belinda Lategan, Elvira del Barco, Francisco Vera-Badillo, Paula Quesada, Robyn Goldstein, Ignacio Cruz, Alberto Ocana,[...]. PLoS One 2015
21
Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity?
Jawad Kiani, Afrasyab Khan, Hina Khawar, Fawad Shuaib, Shahid Pervez. Pathol Oncol Res 2006
Jawad Kiani, Afrasyab Khan, Hina Khawar, Fawad Shuaib, Shahid Pervez. Pathol Oncol Res 2006
27
The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?
A Rhodes, B Jasani. J Clin Pathol 2009
A Rhodes, B Jasani. J Clin Pathol 2009
20
Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?
Niamh M Foley, J M Coll, A J Lowery, S O Hynes, M J Kerin, M Sheehan, C Brodie, K J Sweeney. Pathol Oncol Res 2018
Niamh M Foley, J M Coll, A J Lowery, S O Hynes, M J Kerin, M Sheehan, C Brodie, K J Sweeney. Pathol Oncol Res 2018
40
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.
J M Harvey, G M Clark, C K Osborne, D C Allred. J Clin Oncol 1999
J M Harvey, G M Clark, C K Osborne, D C Allred. J Clin Oncol 1999
7
A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative.
Jigisha P Thakkar, Divyesh G Mehta. Oncologist 2011
Jigisha P Thakkar, Divyesh G Mehta. Oncologist 2011
8
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
6
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, E Rutgers, S Zackrisson, F Cardoso. Ann Oncol 2015
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, E Rutgers, S Zackrisson, F Cardoso. Ann Oncol 2015
6
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
6
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
C W Elston, I O Ellis. Histopathology 1991
C W Elston, I O Ellis. Histopathology 1991
6
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Mitch Dowsett, Torsten O Nielsen, Roger A'Hern, John Bartlett, R Charles Coombes, Jack Cuzick, Matthew Ellis, N Lynn Henry, Judith C Hugh, Tracy Lively,[...]. J Natl Cancer Inst 2011
Mitch Dowsett, Torsten O Nielsen, Roger A'Hern, John Bartlett, R Charles Coombes, Jack Cuzick, Matthew Ellis, N Lynn Henry, Judith C Hugh, Tracy Lively,[...]. J Natl Cancer Inst 2011
6
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
Shuzhen Liu, Stephen K Chia, Erika Mehl, Samuel Leung, Ashish Rajput, Maggie C U Cheang, Torsten O Nielsen. Breast Cancer Res Treat 2010
Shuzhen Liu, Stephen K Chia, Erika Mehl, Samuel Leung, Ashish Rajput, Maggie C U Cheang, Torsten O Nielsen. Breast Cancer Res Treat 2010
6
Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study.
Mitch Dowsett, Jack Cuzick, Chris Wale, Tony Howell, Joan Houghton, Michael Baum. J Clin Oncol 2005
Mitch Dowsett, Jack Cuzick, Chris Wale, Tony Howell, Joan Houghton, Michael Baum. J Clin Oncol 2005
6
It is not time to stop progesterone receptor testing in breast cancer.
R Colomer, M Beltran, J Dorcas, H Cortes-Funes, J Hornedo, V Valentin, C Vargas, C Mendiola, E Ciruelos. J Clin Oncol 2005
R Colomer, M Beltran, J Dorcas, H Cortes-Funes, J Hornedo, V Valentin, C Vargas, C Mendiola, E Ciruelos. J Clin Oncol 2005
18
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.